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Both obesity and diabetes are domestic and international health problems. 
Adiponectin is a protein secreted from fat cells and muscle tissue, which influences 
the metabolism of sugars and fats. For this reason, Adiponectin is a primary target 
for therapeutic treatment of these metabolic diseases. The aim of this study is to 
determine the levels of AdipoR1 and AdipoR2 (the receptors for adiponectin) within 
cardiac, skeletal muscle, and liver tissue samples of mature non-obese rats in order 
to determine if the rat can be used as a model for studies of adiponectin. The data 
from the current study support previous work on the relative levels of AdipoR1 in 
muscle and liver tissues; however, the data from the current study contradict that of 
previous reports, which had suggested that liver had a higher level of AdipoR2 than 
muscle tissue, indicating that further investigation and confirmation is necessary to 




 Both obesity and diabetes are domestic and international health problems. 
Adiponectin is a protein secreted from adipocytes and other tissues such as muscle 
which influences carbohydrate and lipid metabolism. For this reason, Adiponectin is 
a primary target for therapeutic treatment of metabolic diseases. Adiponectin 
interacts with receptors termed AdipoR1 and AdipoR2, which are structurally 
similar to G protein-coupled receptors except with a reverse membrane topology. 
The aim of this study is to determine the levels of AdipoR1 and AdipoR2 within 
cardiac, skeletal, and liver tissue samples of mature non-obese rats. The objective of 
determining potential differences in the tissue levels of these receptors and 
determining any gender differences will be used to establish whether or not the rat 
could make a viable model for further study in adiponectin related research. 
Samples of tissue were homogenized, the lysate centrifuged to produce a fluid 
supernatant, and the supernatants’ protein content analyzed. AdipoR1 and AdipoR2 
levels were determined by ELISA (NeoBiolab, Boston, MA). The data supports a 
difference (p≤ 0.02) in AdipoR1 levels between the liver and muscle tissues 
(gastrocnemius, soleus, and heart), as well as between the genders for the 
gastrocnemius and liver. The levels of AdipoR2 in the liver were also significantly 
lower than in muscles (heart and gastrocnemius), with significant differences (p≤ 
0.01) between the genders for liver. The data from the current study supports 
previous work on the relative levels of AdipoR1 in muscle and liver, but does not 
identify any difference between muscle types. In addition, gender differences in the 
levels of AdipoR1 in gastrocnemius and liver are novel observations. However, the 
data from the current study contradicts that of previous reports, which had 
suggested that liver had a higher level of AdipoR2 than muscle tissue, indicating that 




Obesity and diabetes are local and international health problems that have 
become more prevalent in recent years, with over one third of Americans over the 
age of twenty classified as obese (15). Diseases such as type 2 diabetes (T2D), 
cardiovascular diseases, and some cancers have been linked to obesity (4,7,11). Due 
to the severity of these conditions, the signaling molecules involved in metabolism 
need to be further investigated. Adiponectin is one of the most prominent plasma 
adipokines or adipose-derived cell signaling proteins (1,4,6,7,14). It is a plasma 
protein with insulin-sensitizing properties in addition to anti-inflammatory, and 
anti-plaque forming properties (1,3,4,5,7,9,11,14). Levels of circulating adiponectin 
were found to be lower in obese, insulin resistant, and type 2 diabetic humans and 
animal models of these conditions (1,4,5,9,11). Adiponectin has also been shown to 
influence many other functions including decreasing both inflammation and cellular 
apoptosis (2,4,7,11).  
The 30-kDa adiponectin monomer (Figure 1) consists of an amino-terminal 
domain followed by a collagen-like domain and a carboxyl-terminal globular domain 
(1,7,14). The amino acid-terminal domain contains a 17-amino acid portion that 
serves as a signal sequence to propel it into the secretory pathway (22). The 
primary amino acid sequence of the adiponectin gene is highly conserved, at greater 
than 80% homology, among several species including humans, mice and rats (17). 
There are three major forms of circulating adiponectin (Figure 1): a low-molecular-
weight (LMW) trimer, a middle-molecular-weight (MMW) hexamer, and a high-
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molecular-weight (HMW) 12- 18-mer (7,8,9,12). 
 
Figure 1: Structure of adiponectin. Adiponectin contains three domains and a signal 
sequence. After post-translational modifications such as glycosylation, adiponectin is secreted 
from the cell as the basic trimer unit, a low-molecular weight (LMW) isoform, or a high 
molecular weight (HMW) isoform. Other abbreviations: amino-acids (aa), carboxy-terminal 
(C), amino-terminal (N) (22). 
 The LMW trimer is the basic building block of adiponectin and is formed via 
the hydrophobic interactions within the globular heads and stabilized by the non-
covalent interactions of the collagenous domains (17). The MMW complex, which is 
not shown in Figure 1, is formed via the disulfide bond of two cysteine residues 
located in the N-terminal variable region (11,17, 21). The HMW complex is formed 
in a similar way, with the N-terminal region associations allowing for disulfide 
bonds between the cysteine residues (17, 21). The HMW is the most active form, 
making it the most relevant to studies of insulin sensitivity and diabetes (7,9,11,14). 
It is the ratio of HMW to total adiponectin, not the total adiponectin levels, that 
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correlates with levels of insulin sensitivity (17,19). Further, the elevation of LMW 
and MMW in cerebrospinal fluid has been shown to aggravate obesity by not only 
increasing food intake, but also by suppressing energy expenditure (17). This 
suggests that there may be adiponectin targets in the central nervous system that 
can be manipulated for therapy. 
A sexual dimorphism of adiponectin concentration has been reported in both 
humans and rodents, with males reported to have significantly lower plasma levels 
of total adiponectin than females, which has been attributed primarily to the 
inhibitory actions of testosterone on adiponectin secretion (17). It has been noted 
that neither castration nor testosterone treatment interferes with the abundance of 
adiponectin mRNA, suggesting that the adiponectin levels in males are being 
affected by preferential secretion of the LMW and MMW over the HMW (17). This 
selective secretion therefore implies that there are at least two different secretory 
mechanisms, which allows testosterone to selectively inhibit the release of HWM 
adiponectin (17). A study from Bogan and Lodish (18) showed two distinct 
pathways exist, which allows for constitutive as well as regulated secretion. 
Adiponectin significantly affects insulin sensitivity through direct action on 
liver and muscle (1,4,5,11,19). The biological effects depend not only on the 
circulating concentration of adiponectin, but also on the expression levels and 
functionality of its receptors (1,4,7). Reduced levels of circulating adiponectin and 
its receptors can be caused by genetic factors within the adiponectin gene itself as 
well as environmental factors that cause obesity, such as a high fat diet (3,4,14). It 
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has also been found that plasma adiponectin levels are inversely associated with 
obesity, diabetes, glucose, lipid, and insulin resistance, whereas the receptor levels 
are positively associated with these disease states (10). 
Adiponectin regulates skeletal muscle energy metabolism by stimulating free 
fatty acid (FFA) oxidation by mitochondria as well as glucose uptake via enhanced 
GLUT4 translocation to the plasma membrane (1,3,4,7). Impaired adiponectin levels 
have been linked with T2D (3,5,7), where subjects with high concentrations of 
circulating adiponectin were 40% less likely to develop T2D, indicating that 
adiponectin could be used as a predictor for future development of T2D (3). It has 
also been shown that circulating adiponectin levels are decreased in rodents fed 
high fat diets, while the addition of adiponectin via injection results in an 
improvement in insulin resistance (4,7).  
The pleiotropic effects of adiponectin are mediated by two receptors (Figure 
2) named AdipoR1 and AdipoR2  (1,4,5,7,11). Both are the major receptors for 
adiponectin in vivo and play an important role in glucose metabolism and insulin 
sensitivity (1,4,7). AdipoR1 is ubiquitously expressed, but is predominately found in 
skeletal muscle, whereas AdipoR2 is reported to be most abundant in liver 
(1,3,4,5,7,10,11). AdipoR1/R2 have also been discovered on pancreatic β cells 
suggesting they may also play a role in insulin secretion (19). AdipoR1/R2 double-
knockout mice have conclusively shown that without these receptors, the major 
adiponectin-induced metabolic effects (such as increased insulin sensitivity) were 
completely obliterated (20). 
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The two receptors are approximately 67% homologous in their amino acid 
sequence (1,4,7). The receptors consist of a seven-transmembrane domain similar 
to G-protein-coupled receptors except for the C-terminus and N-terminus being 
reversed so that the adiponectin receptors’ C-terminus is extracellular and the N- 
terminus is cytosolic (1,4,7,19), which can be seen in Figure 2. AdipoR1 and 
AdipoR2 also differ from G-protein- coupled receptors in their downstream 
signaling mechanisms (1,20). 
 
Figure 2: AdipoR1 and AdipoR2 structure.  AdipoR1/R2 share a 67% homology in 
their amino acid sequence and consist of seven transmembrane domains. The C-terminus is 
located in the extracellular space, while the N-terminus is located in the intracellular space 
(19). 
AdipoR1 has a high affinity for globular Adiponectin (gAd), which consists of 
just the c-terminal globular domain, and a low affinity for the full adiponectin (fAd) 
(1,3,4,5,7,10,11). AdipoR2 has an intermediate affinity for both the fAd and gAd 
(1,4,5,7,10,11). Studies suggest that AdipoR1 plays a crucial role in mitochondrial 
dysfunction and insulin resistance in muscle and thus may be a potential 
therapeutic target (1,3,4). AdipoR1 and AdipoR2 were significantly decreased in 
muscles and adipose tissue of insulin-resistant subjects, compared to control 
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subjects (3,5, 19). It has been suggested that AdipoR1 directly affects the expression 
of genes that code for hepatic gluconeogenic enzymes therefore decreasing 
endogenous glucose production (20).  AdipoR2, unlike AdipoR1, has been shown to 
increase glucose uptake, but it has no effect on the gene expression involved with 
gluconeogenesis (20). AdipoR2 has also been shown to reduce inflammation and 
oxidative stress, which may explain the improvement in liver insulin resistance (20). 
The topic of this thesis is determination of levels of the two main receptors 
for adiponectin, which warrant further study as they may prove to be a valuable tool 
for predicting diabetes and other obesity-related diseases as well as being a focus 
for therapeutic intervention. The aim of this thesis is to assess the level of 
AdipoR1/R2 in multiple tissue types for comparison and to consider if the rat will 
make a viable model for the study of the role of adiponectin in diabetes and obesity. 
I hypothesize that the levels of AdipoR1/R2 will be comparable to those levels 
reported in other organisms, and that the rat will indeed be a practical model for 
further testing. 
Methods  
Tissue samples, obtained from mature male rats utilized by the Price 
Institute of Surgical Research (Louisville, KY) and mature female sentinel rats from 
the Research Resources Center (University of Louisville), were frozen in liquid 
nitrogen and stored at -80°C until used. Milligram quantities of frozen tissue 
samples were weighed using a Mettler AE 100 (Mettler-Toledo Ltd., Leicester, UK) 
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and homogenized with a Micro-vial Homogenizer (Wilmad LabGlass, Elk Grove 
Village, IL) at 4°C in 0.6 ml of cold buffer (20 mM Tris-HCl, pH7.5, 50 mM 2-
mercaptoethanol, 5 mM EGTA, 2 mM EDTA, 1mM phenylmethylsulfonyl fluoride, 10 
mM sodium fluoride, 25 μg/ml leupeptin, 2 μg/ml aprotinin) (13). The homogenized 
samples were centrifuged at 10,000 RPM (8161 g) for ten minutes at 4°C. The 
supernatants were collected and stored at -80°C until analyses were conducted (13). 
The total protein content of each sample was measured in duplicate using a 
protein assay (16) with bovine serum albumin (Pierce, Rockford, IL) as a standard. 
The absorbance was measured on a Milton Roy Spectronic 601 at 650 nm and the 
duplicate readings were averaged to form a standard curve on Microsoft Excel along 
with the line of best fit. The tissue samples were thawed on ice and each of the 
tissue types (liver, gastrocnemius, soleus, and heart) were run (with 3 μL of sample 
and 997 μL of DI water) and the absorbance read. Using the line of best fit from the 
standard curve, the amount of total protein was determined for all samples. 
Competitive ELISAs (NeoBiolab, Cambridge, MA) were run to assess the total 
amount of AdipoR1/R2. First, all kit components and samples were brought up to 
room temperature. Next, 200 μL of each sample was pipetted into labeled Eppendorf 
tubes and 20 μL of balance solution was added and all tubes vortexed. 100 μL of the 
samples as well as the standards were pipetted into the pre-blocked wells in 
duplicate in a 96 well plate. After all wells were loaded, 50 μL of enzyme conjugate 
was added to each well. The plate was then incubated for one hour in humid 
chamber kept at 37° C. 
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Once the incubation was complete, the plate was washed five times with 400 
μL of wash solution, which had been diluted from 100x concentration to 1x 
concentration. After each wash, the plate was inverted to remove the liquid and 
blotted dry. Next, 50 μL of Substrate A was added to each well, followed by the 
addition of 50 μL of Substrate B. The plate was then covered in foil and incubated 
again, this time for fifteen minutes at room temperature in the dark. After fifteen 
minutes, 50 μL of the Stop Solution was added to each well and the plate was 
immediately read at 450 nm using an ELX 808 Ultra Microplate Reader. All samples, 
including the standards and blanks were run in duplicate and the plate reader 
values averaged in order to determine the concentration of AdipoR1/R2 using the 
standard curve. Finally, data analyses (ANOVA, t-test, significant difference 
[p<0.05]) were performed using Microsoft Excel and StatsPlus. 
Results 
Protein assay to determine total protein content 
 In order to determine the amount of total protein in each tissue homogenate 
for use in expressing total receptor levels, protein assays were performed as 
described in the methods section. Using a standard curve generated for each assay 
(an example of one of the standard curves can be seen in Figure 3), the average 
amount of protein per milliliter of sample was determined for each tissue 
homogenate. The standard curves all had an R2 value of at least 0.99, meaning the 
standards fell very close to the line of best fit. The equations for the line of best fit 
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were then rearranged to solve for “x”; then that number was corrected for dilution 
in order to calculate mg of protein per mL of homogenized sample. The average 
amount of protein per mL was then found for the genders for each tissue type, along 
with the standard deviation. At least six animals (three from each gender) for each 
tissue were measured in duplicate.  
 
Figure 3: Typical Protein assay results for Liver, Heart, and Gastrocnemius. A 
standard curve for both male and female samples of the liver, heart, and gastrocnemius with 
an R2 value of 0.99. The other standard curves generated look similar to this and have an R2 
value of at least 0.99 as well. At least three animals from each gender (six total animals) were 
used for each tissue, and all samples (including standards) were run in duplicate. 
 
ELISA to determine the content of AdipoR1 and AdipoR2 
To assess the total AdipoR1, a competitive ELISA was run as described in the 
methods section. A standard curve was made using the averaged readings of the 
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standards provided by the ELISA kit (Figure 4A) in order to obtain two lines of best 
fit. The standard curve was split into two separate graphs in order to get the most 
accurate line of best fit. Using the lines of best fit, the total amount of AdipoR1 and 
the standard error were calculated (Figure 4B). A t-test was run comparing liver to 
heart, liver to gastrocnemius, and gastrocnemius to heart, with the two-tailed p-
values listed in Figure 4C after the ANOVA indicated there were significant 
differences (p<0.008) between the groups. A bar graph (Figure 4D) was compiled 
using that data and anything with a p-value of less than 0.05 was marked as 
significantly different. I found that there was a significant difference in the amount 
of AdipoR1 in the liver compared to the other tissue homogenates; however there 
were no significant difference found among the other tissues. A Bonferroni 
correction was done and it was found that the only significant difference that holds 
up to the new α-value (α≤0.008) was the liver vs. soleus levels of AdipoR2.  A total of 
ten animals were used (five of each gender) for each tissue type, and all samples 
(including standards) were run in duplicate. 
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Figure 4: Total AdipoR1 in tissue homogenates. A) The standard curve generated 
from standards supplied with the ELISA kit. B) The average amount of total AdipoR1 for each 
of the tissue types accompanied by standard error. C) The p-values from the t-tests comparing 
the liver to the heart, the liver to the gastrocnemius (gastroc), the liver to the soleus, the heart 
to the soleus, gastrocnemius to the heart, and gastrocnemius to the soleus. D) A bar graph 
showing total AdipoR1 levels with significant differences marked. There were a total of ten 
animals used (five of each gender) for each tissue type, and all samples (including standards) 
were run in duplicate. 
  
To assess the total AdipoR2 a competitive ELISA was used as previously 
described above. A standard curve was constructed using the averaged readings of 
the standards provided by the ELISA kit (Figure 5A) in order to obtain a line of best 
fit. The total amount of AdipoR2 was found (Figure 5B) and three separate t-tests 
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run to compare the liver to heart, the liver to gastrocnemius, and gastrocnemius to 
heart (Figure 5C) after ANOVA indicated there were significant differences 
(p<0.003) between the groups. These data were then graphed and any comparison 
with a p-value less than 0.05 were marked as significantly different (Figure 5D).  A 
significant difference was found between the levels of AdipoR2 in the liver to all 
other tissues; however there was no significant difference between the other 
tissues. A Bonferroni correction was performed and all significant differences found 
for AdipoR2 held true with the new α-value (α≤0.0167). All tissues were run from 
six different animals (three of each gender) and all samples (including standards) 
were done in duplicate. The totals for both AdipoR1 and AdipoR2 were compiled 
into a single graph (Figure 6) and the significant differences indicated. The totals for 
AdipoR1 and AdipoR2 for each tissue were tested for significant difference, but only 
the heart showed significant difference at p<0.007. A Bonferroni correction was 
performed and the significant difference between the receptor levels for the heart 
held true at the new alpha value of α≤0.0167.  
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Figure 5: Total AdipoR2 in tissue homogenates. A) The standard curve generated 
using the standards provided by the ELISA kit. B) The average AdipoR2 for each tissue type 
accompanied by the standard error. C) The p-values from the t-tests comparing the liver to the 
heart, the liver to the gastrocnemius, and the gastrocnemius to the heart. D) A bar graph 
showing the total AdipoR2 for each tissue type with significant differences marked. There 
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were a total of six animals used (three of each gender) for each tissue type, and all samples 
(including standards) were run in duplicate. 
 
Figure 6: Total AdipoR1 and AdipoR2. Significant difference within the individual 
receptor levels for different tissue has been marked. 
 
Tissue content of AdipoR1 and AdipoR2 by sex 
The data from both the AdipoR1 and AdipoR2 ELISAs were expressed by 
gender for the tissue types. The average amount of receptor for each gender and 
standard error was calculated for each tissue homogenate (Figure 7B/D). T-tests 
were run between each gender for all the tissue homogenates and the p-values 
recorded (Figure 7C/E). The results were then compiled into a graph (Figure 7A) 
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and the significant differences (p<0.05) between genders marked.  I found that there 
was significant difference between the male and female liver levels for both 
receptors. There was also a significant different between the female levels of 
adipoR1 and the male levels; however, there was no significant difference between 
the male and female levels of adipoR2. There was also no significant difference 
between the male and female receptor levels for either receptor. A Bonferroni 
correction was performed and all significant differences found for AdipoR1/R2 
between the sexes held true with the new α-value (α≤0.0167). For the AdipoR1 
samples, five different animals of each gender were used for each tissue type and 
they were run in duplicate. For the AdipoR2 samples, three different animals for 
each gender were used for each tissue type and these were also run in duplicate. 
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Figure 7: Adiponectin receptor levels by sex. A) A bar graph showing the levels of the 
two adiponectin receptors for each gender related to tissue type. Significant difference 
between the genders has been marked. B) The average amount of AdipoR1 for male and 
female tissue as well as the standard error for each gender. C) The p-values of the t-tests 
comparing the male and female AdipoR1 levels for each tissue. D) The average amount of 
AdipoR2 for male and female tissue as well as the standard error for each gender. E) The p-
values of the t-tests comparing the male and female AdipoR2 levels for each tissue. All 
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samples were run in duplicate with at least three animals of each gender used for each tissue 
type. 
Discussion 
 As noted in the literature (1,3,4,5,7,10,11), the present study has confirmed a 
higher AdipoR1 level in muscles compared to liver. Furthermore, this study 
demonstrated that there was no significant difference between the total AdipoR1 
levels between muscle types, as can be seen in Figure 4. Since AdipoR1 is best 
known for its ability to increase mitochondrial function and thereby improve 
metabolic capacity as well as glucose uptake, it follows that the levels would be 
higher in the muscles than the liver since the muscles consume glucose as their main 
form of energy. This makes AdipoR1 a potential target for pharmaceutical therapies 
that could potentially increase the amount of AdipoR1 found in the muscle cell 
membranes or increase the sensitivity of the receptor to adiponectin in an effort to 
allay the disease states associated with diabetes and obesity. 
 This study also found that the gastrocnemius and liver are significantly 
different between the genders (Figure 7). The livers from male rats have a 
significantly higher amount of AdipoR1 than those from female, and the female 
gastroc samples have a significantly higher amount of AdipoR1 compared to the 
males (Figure 7). These findings may correlate to previous results from this lab that 
suggested that there was a higher level of lower molecular weight (LMW) 
adiponectin produced by female muscles compared to male muscles (data not 
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shown). Because the AdipoR1 receptor has been reported to have a higher affinity 
for globular adiponectin (LMW), this may reveal a physiological relevance.  
 Contrary to the literature (1,3,4,5,7,10,11), the total level of AdipoR2 found in 
the liver was significantly lower than that of the muscle tissues tested (Figure 5). 
Previous studies (1,3,4 have found that the levels of AdipoR2 are significantly higher 
in the liver than in the muscles.  The ability of AdipoR2 to increase fatty acid 
oxidation in the liver (19) is important in re-sensitizing the liver to insulin. If there is 
an increase in oxidative stress in the liver, gluconeogenesis will increase in the liver 
and glucose uptake will decrease glucose uptake in the liver and skeletal muscles 
(23). This effect of adipoR2 makes is a potential target for pharmaceutical therapy as 
well, but due to the lowered levels found in this study, it may pose difficulties for 
further therapeutic testing. The lowered amount in the rats used for this study could 
indicate that the rats were under oxidative stress before death.  To clarify the 
present results for AdipoR2, further studies such as immunoblotting should be 
performed to confirm the ELISA results. 
 There was a significant difference in AdipoR2 levels found between the 
genders for the liver, but there were no significant differences between the genders 
for the other tissue samples (Figure 7). The differences between the genders for the 
liver may have a physiological relevance as well, but further study is needed. 
 The levels of AdipoR1/R2 in the liver were significantly different between the 
females as well as between the males. The levels of AdipoR1/R2 in the heart were 
significantly different between the females, but not between the males. Finally, the 
levels of AdipoR1/R2 in the gastrocnemius were significantly different between the 
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females, but not between the males. A sexual dimorphism has been reported in the 
levels of secreted adiponectin (17) in humans and rodents, so it is possible that 
there is a similar mechanism that affects the amount of AdipoR inserted into the 
cellular membrane. 
Based on the data gathered so far, the rat makes a comparable model to 
mouse and human when it comes to AdipoR1 receptors. However, my data indicated 
that it might not make a good model for AdipoR2 receptors since AdipoR2 receptors 
in humans and mice are reported to be higher in the liver than in muscle 
(1,3,4,5,7,10,11). Further studies are required to confirm the perceived 
inconsistencies for AdipoR2 from the current findings. This is needed in order to 
determine if rats are different from mice and humans for this receptor. 
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